# IMMUNE DESIGN CORP.

IMMUNE DESIGN CORP. is a company headquartered in Seattle, WA, United States.

## Company overview

- **Legal name:** IMMUNE DESIGN CORP.
- **Former names in filing history:** VACCSYS INC (2008-06-13 to 2008-06-13)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Seattle, WA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001437786

## About

IMMUNE DESIGN CORP. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001437786, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-13, it reported annual revenue of USD 2,196,000; net income of USD -54,758,000; total assets of USD 100,960,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $2.2M (USD 2,196,000)
- **Net income:** -$54.8M (USD -54,758,000)
- **Total assets:** $101.0M (USD 100,960,000)
- **Cash and equivalents:** $77.9M (USD 77,941,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $7.2M (USD 7,195,000)
- **Net income:** -$51.9M (USD -51,862,000)
- **Total assets:** $153.8M (USD 153,834,000)
- **Cash and equivalents:** $72.5M (USD 72,454,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $13.3M (USD 13,260,000)
- **Net income:** -$53.5M (USD -53,530,000)
- **Total assets:** $114.5M (USD 114,495,000)
- **Cash and equivalents:** $45.2M (USD 45,214,000)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $9.5M (USD 9,510,000)
- **Net income:** -$39.4M (USD -39,445,000)
- **Total assets:** $116.1M (USD 116,145,000)
- **Cash and equivalents:** $112.9M (USD 112,921,000)

## Recent SEC filings

- Form 8-K — filed 2019-04-02 — period 2019-04-02 — 8-K
- Form 10-K/A — filed 2019-03-28 — period 2018-12-31 — FORM 10-K/A
- Form 10-K — filed 2019-03-13 — period 2018-12-31 — FORM 10-K
- Form 8-K — filed 2019-02-21 — period 2019-02-20 — 8-K
- Form 8-K — filed 2019-01-08 — period 2019-01-03 — FORM 8-K
- Form 8-K — filed 2018-12-10 — period 2018-12-06 — FORM 8-K
- Form 8-K — filed 2018-11-13 — period 2018-11-07 — FORM 8-K
- Form 10-Q — filed 2018-11-06 — period 2018-09-30 — FORM 10-Q
- Form 8-K — filed 2018-11-06 — period 2018-11-06 — FORM 8-K
- Form 8-K — filed 2018-10-11 — period 2018-10-11 — FORM 8-K
- Form 8-K — filed 2018-09-04 — period 2018-08-28 — FORM 8-K
- Form 10-Q — filed 2018-08-01 — period 2018-06-30 — FORM 10-Q

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/immune-design-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology